The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Porous silk fibroin 3‐D scaffolds for delivery of bone morphogenetic protein‐2 in vitro and in vivo
Abstract
Bone morphogenetic protein‐2 (BMP‐2) plays a key role in osteogenesis. Biomaterials used for the sustained delivery of BMP‐2 in vivo have shown therapeutic benefits. In the present study, BMP‐2 was loaded in porous silk fibroin scaffolds derived from silkworm cocoons (2.4 ± 0.14 μg per scaffold). The release profile of BMP‐2 under dynamic culture conditions (spinner flasks) showed that after 1 week in culture 25% of the initial BMP‐2 was retained adsorbed to the scaffold; up to 4 weeks no additional BMP‐2 was released. BMP‐2 induced human bone marrow stromal cells (hMSCs) to undergo osteogenic differentiation when the seeded scaffolds were cultured in medium supplemented with osteogenic stimulants for 4 weeks, based on elevated alkaline phosphatase activity, calcium deposition, and transcript levels for bone sialoprotein, osteopontin, osteocalcin, BMP‐2, and cbfa‐1. Micro‐computed tomography revealed densely deposited mineral at the center of the scaffolds. In contrast, hMSCs cultured in control scaffolds (no BMP‐2) exhibited limited osteogenesis. When implanted in critical sized cranial defects in mice, scaffolds loaded with BMP‐2 and seeded with hMSCs resulted in significant bone ingrowth. These results were qualitatively similar to scaffolds loaded with BMP‐2 but no hMSCs or with BMP‐2 and hMSCs but not pregrown into bone‐like tissue. Bone‐related outcomes were improved when compared with the scaffold controls implanted without BMP‐2. These studies illustrate the potential use of slow degrading silk fibroin 3‐D scaffolds loaded with BMP‐2, in combination with hMSCs, in osteogenesis studies in vitro and in vivo, and provide a new range of material properties for these applications. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2006
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Altman, G. H., Diaz, F., Jakuba, C., Calabro, T., Horan, R. L., Chen, J., Lu, H., Richmond, J., & Kaplan, D. L. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00353-8 · Cited by 3,458
Self-citationBone Compressive Strength: The Influence of Density and Strain Rate
Carter, D. R., & Hayes, W. C. (1976) · Science · doi:10.1126/science.996549 · Cited by 709
RUHE, Q. P., HEDBERG, E. L., PADRON, N. T., SPAUWEN, P. H. M., JANSEN, J. A., & MIKOS, A. G. (2003) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200300003-00013 · Cited by 186
Cited by
Vepari, C., & Kaplan, D. L. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.013 · Cited by 2,561
Self-citationSilk fibroin biomaterials for tissue regenerations
Kundu, B., Rajkhowa, R., Kundu, S. C., & Wang, X. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.043 · Cited by 1,391
Biomimetic materials for tissue engineering
Ma, P. X. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.041 · Cited by 1,310
In vivo degradation of three-dimensional silk fibroin scaffolds
Wang, Y., Rudym, D. D., Walsh, A., Abrahamsen, L., Kim, H.-J., Kim, H. S., Kirker-Head, C., & Kaplan, D. L. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.05.002 · Cited by 789
Self-citationSilk fibroin as biomaterial for bone tissue engineering
Melke, J., Midha, S., Ghosh, S., Ito, K., & Hofmann, S. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.09.005 · Cited by 789
Water-insoluble silk films with silk I structure
Lu, Q., Hu, X., Wang, X., Kluge, J. A., Lu, S., Cebe, P., & Kaplan, D. L. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2009.10.041 · Cited by 654
Self-citationBiopolymer based nanomaterials in drug delivery systems: A review
Jacob, J., Haponiuk, J. T., Thomas, S., & Gopi, S. (2018) · Materials Today Chemistry · doi:10.1016/j.mtchem.2018.05.002 · Cited by 573
Elastomeric biomaterials for tissue engineering
Chen, Q., Liang, S., & Thouas, G. A. (2013) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2012.05.003 · Cited by 564
Silk fibroin as a vehicle for drug delivery applications
Wenk, E., Merkle, H. P., & Meinel, L. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.007 · Cited by 556
Self-citationBessa, P. C., Casal, M., & Reis, R. L. (2008) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.74 · Cited by 549
Silk Materials – A Road to Sustainable High Technology
Tao, H., Kaplan, D. L., & Omenetto, F. G. (2012) · Advanced Materials · doi:10.1002/adma.201104477 · Cited by 529
Self-citationBiomedical applications of chemically-modified silk fibroin
Murphy, A. R., & Kaplan, D. L. (2009) · Journal of Materials Chemistry · doi:10.1039/b905802h · Cited by 521
Self-citationSilk fibroin nanoparticle as a novel drug delivery system
Mottaghitalab, F., Farokhi, M., Shokrgozar, M. A., Atyabi, F., & Hosseinkhani, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.020 · Cited by 444
Silk nanospheres and microspheres from silk/pva blend films for drug delivery
Wang, X., Yucel, T., Lu, Q., Hu, X., & Kaplan, D. L. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.002 · Cited by 434
Self-citationBiopolymer-based functional composites for medical applications
Park, S.-B., Lih, E., Park, K.-S., Joung, Y. K., & Han, D. K. (2017) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2016.12.003 · Cited by 429
Wang, X., Wenk, E., Zhang, X., Meinel, L., Vunjak-Novakovic, G., & Kaplan, D. L. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.021 · Cited by 421
Self-citationSurface engineered and drug releasing pre-fabricated scaffolds for tissue engineering
Chung, H. J., & Park, T. G. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.015 · Cited by 401
Silk-based delivery systems of bioactive molecules
Numata, K., & Kaplan, D. L. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.009 · Cited by 385
Self-citationSilk-based biomaterials for sustained drug delivery
Yucel, T., Lovett, M. L., & Kaplan, D. L. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.059 · Cited by 359
Self-citationDegradation mechanism and control of silk fibroin
Lu, Q., Zhang, B., Li, M., Zuo, B., Kaplan, D. L., Huang, Y., & Zhu, H. (2011) · Biomacromolecules · doi:10.1021/bm101422j · Cited by 344
Self-citationBiocompatibility evaluation of silk fibroin with peripheral nerve tissues and cells in vitro
Yang, Y., Chen, X., Ding, F., Zhang, P., Liu, J., & Gu, X. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.004 · Cited by 333
Development and evaluation of silk fibroin-based nerve grafts used for peripheral nerve regeneration
Yang, Y., Ding, F., Wu, J., Hu, W., Liu, W., Liu, J., & Gu, X. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.09.001 · Cited by 326
In vitro evaluation of electrospun silk fibroin scaffolds for vascular cell growth
Zhang, X., Baughman, C. B., & Kaplan, D. L. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.01.022 · Cited by 325
Self-citationSilk scaffolds in bone tissue engineering: An overview
Bhattacharjee, P., Kundu, B., Naskar, D., Kim, H.-W., Maiti, T. K., Bhattacharya, D., & Kundu, S. C. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.09.027 · Cited by 318
Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine
Sundelacruz, S., & Kaplan, D. L. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.03.017 · Cited by 306
Self-citationBioactive Silk Protein Biomaterial Systems for Optical Devices
Lawrence, B. D., Cronin-Golomb, M., Georgakoudi, I., Kaplan, D. L., & Omenetto, F. G. (2008) · Biomacromolecules · doi:10.1021/bm701235f · Cited by 306
Self-citationNatural and genetically engineered proteins for tissue engineering
Gomes, S., Leonor, I. B., Mano, J. F., Reis, R. L., & Kaplan, D. L. (2012) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.07.003 · Cited by 261
Self-citationBhattarai, D. P., Aguilar, L. E., Park, C. H., & Kim, C. S. (2018) · Membranes · doi:10.3390/membranes8030062 · Cited by 261
Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration
El Bialy, I., Jiskoot, W., & Reza Nejadnik, M. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2147-x · Cited by 257
A comprehensive review on silk fibroin as a persuasive biomaterial for bone tissue engineering
Li, M., You, J., Qin, Q., Liu, M., Yang, Y., Jia, K., Zhang, Y., & Zhou, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032660 · Cited by 64
Uebersax, L., Apfel, T., Nuss, K. M. R., Vogt, R., Kim, H. Y., Meinel, L., Kaplan, D. L., Auer, J. A., Merkle, H. P., & von Rechenberg, B. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.05.008 · Cited by 61
Self-citationRecent Advances in Silk Fibroin-Based Composites for Bone Repair Applications: A Review
Zhu, S., Zhang, Q., Xu, X., Liu, Z., Cheng, G., Long, D., Cheng, L., & Dai, F. (2025) · Polymers · doi:10.3390/polym17060772 · Cited by 36
Metadata
- Authors
- Karageorgiou, V., Tomkins, M., Fajardo, R., Meinel, L., Snyder, B., Wade, K., Chen, J., Vunjak‐Novakovic, G., & Kaplan, D. L.
- Venue
- Journal of Biomedical Materials Research Part A
- Publisher
- Wiley
- Published
- 2006-04-24
- Volume
- 78A
- Issue
- 2
- Pages
- 324-334
- ISSN
- 1549-3296 (ISSN-L)
- 1552-4965
- OpenAlex
- W2119964073
- Cited by
- 213
- References
- 3
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.